Key result
Catheter-based renal denervation effectively reduces office, home, and ambulatory blood pressure metrics and can be considered an adjunctive treatment for hypertension.
Why the study?
Does catheter-based renal denervation reduce blood pressure in patients with hypertension?
Does catheter-based renal denervation reduce blood pressure in patients with hypertension?
Catheter-based renal denervation is an effective adjunctive treatment for reducing blood pressure in patients with hypertension.
Extends observational support for renal denervation; leaves open confirmation of durability and selection criteria in randomized trials.
Evidence from sham-controlled trials shows that RDN effectively reduces office, home, and ambulatory BP metrics, supporting its clinical use in the management of hypertension.In addition to adequate lifestyle modification and antihypertensive medication, RDN can be considered as an adjunctive treatment for hypertension in clinical practice, but additional research is needed to provide data on the effects of RDN in specific patient populations, including those based on ethnicity and comorbidities.
No takes yet. Share an insight, caveat, or question.
Kazuomi Kario (2024) conducted a review in Hypertension. Catheter-Based Renal Denervation (RDN) was evaluated on Office, home, and ambulatory BP metrics. Catheter-based renal denervation effectively reduces office, home, and ambulatory blood pressure metrics and can be considered an adjunctive treatment for hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: